Welcome to PhorTech International PhorTech International in a nutshellLearn about the PhorTech panel of life science researchers Learn about our multi-client reports and custom market research See our client list and read testimonials about our work. Find out how to contact us

More About Reports & Services

To learn more about our reports and services, click on the hyperlinks below:

Market Research Reports & Availability - Chronological Listing

Market Research Reports & Availability - by Subject Area

Custom Consulting Services

PhorTech International

 

2005/2006 U.S. MSPPSA report on DNA Sequencing Market Analysis

221 pages, 164 graphs and tables

Published: October 8, 2007

Price: $4195

 

Sequencing Market Continues to Evolve as More Researchers Rely on Sequencing Services

Of the estimated 152,700 life science researchers working in the United States, we calculate that 60,970 individuals are currently using DNA sequencing. What has changed is that the vast majority of these now rely upon out-sourcing their sequencing work to core facilities and off-site sequencing services. In our last U.S. sequencing survey in 1999, 59.1% of researchers reported performing at least some of their sequencing in their own laboratory. In our latest study, this number has plummeted to 21.4%.

 

 

These are a few of the conclusions of a new 221 page study, which forms part of PhorTech's MSPPSA series. This series has been developed over the past 12 years to periodically measure market size, growth rates, and supplier performance in key areas of bioresearch. This report continues the analysis of DNA sequencing markets with a detailed investigation of sequencing at core facilities and sequencing services. Included are critical criteria for selection, frequently mentioned problems, as well as key metrics such as template throughput per month and the costs of sequencing through both core facilities and commercial sequencing services.

 

 

Complete analyses for respondents' monthly spending on sequencing services allow us to extrapolate to the current size of these market segments both in terms of dollars and volume of templates sequenced.

 

 

The report includes extensive sections covering the technical aspects of sequencing sample preparation and the methods used in sequencing itself, as well as a number of key aspects surrounding sequencing. For example, in the following table, we see population estimates for researchers working with various sequencing applications.

 

Population Estimate of U.S. Researchers Working with Sequencing Applications

Sequencing Application

# US Researchers

Cloning confirmation

45,090

cDNA sequencing

37,150

Mutation analysis

32,840

General fragment analysis

10,500

SNP analysis

8,350

Microsatellite analysis

5,110

Footprinting

1,880

AFLP

1,350

Gel retardation analysis

1,210

RAPD

400

Other

7,400

Total

60,970

 

This section includes an analysis of the raw sequence data generated by respondents and projected to be generated in one year, the numbers of sequencing reactions run, an analysis of the template throughput and types of templates being prepared. We also examine the current usage of various labeling methods, shown below.

 

 

By asking respondents to itemize automated sequencing instrumentation they have acquired in the past, describing the brand and model of the instrument, the number of units, the years of acquisition, and the location of the instruments, we have produced an invaluable database of installed instru­mentation. From this wealth of data, we are able to present detailed graphs of both market share and growth rates for the past decade.

 

We also asked respondents to itemize sequencing enzymes they purchase, once again describing the types in detail. From this database, we can calculate unit market shares for these products.

 

 

An entire section of the report is dedicated to future purchase plans and we use this data to project future growth rates and lines of products forecast to grow least and most rapidly. Over-confident suppliers will ignore these statistics at their own peril, while market-savvy suppliers will use this data to increase their market share and avoid market dead zones.

 

Customer satisfaction ratings are measured separately for leading vendors of automated sequencers. We probed carefully in these areas and asked respondents to rate manufacturers in four key areas (best field service, highest throughput, most reliable quality, and most committed to sequencing). These ratings are invaluable both for suppliers to measure their own performance as well as to discover areas of weakness for their major competitors that can be used to obtain competitive advantage.

 

Finally, the report itemizes literally hundreds of specific verbatim comments including the features of an automated sequencer most important to respondents. Respondents also suggested improvements they would most like to see in automated sequencers and described factors which would cause them to switch from using a core facility or sequencing service to using their own sequencing instrument. Reading these comments is equivalent to spending weeks of time in the field with end-users and provides essential insight for suppliers.

 

This report is undoubtedly the most comprehensive analysis of the current market DNA sequencing in North America. It has already been purchased by astute competitors determined to strengthen their position in this lucrative market. Enhanced by over 160 color graphs and tables, this study provides a penetrating analysis and should be considered essential reading for anyone seriously intending to succeed in this competitive area. Companies mentioned in the report are listed below.

 

Companies Mentioned in This Report

Abbott Laboratories

Agencourt

Ambion

Amresco

Applied Biosystems

Bayer/VGI

BD Biosciences

BDT

Beckman-Coulter

Bio-Rad Laboratories

Bioline

Biosearch

Bioshop

Boehringer Mannheim

Cambrex

Cambridge

CLP

Denville

Difco

DNAStar

Edge Biosystems

Epicentre

Eppendorf

Espec

Fermentas Life Sciences

Fidelity Systems

Fisher Scientific

FMC Corporation

GE Healthcare

Hitachi

IBI

ICN

IDT

Invitrogen Corporation

J T Baker

LI-COR

Machery-Nagel

Mallinckrodt

Midwest Scientific

Millipore Corporation

MWG Biotech

National Diagnostics

New England Biolabs

PerkinElmer

Promega

PyroSequencing

Qbiogene

Qiagen

Roche

Sigma Genosys

SpectruMedix

Stratagene

TaKaRa

Ultra Scientific

USB

VWR International

Zymo

 

A copy of the original press release for this report as well as a detailed summary of the report including table of contents and list of tables and graphs, as well as the methodology and project objectives, the survey demographics, and a copy of the survey questionnaire can be downloaded from link at the bottom of this page.

 

 

Original press release for this reportSee original press release for this report in Adobe Acrobat format.

Detailed contents, methodology, demographics, and questionnaire for this reportSee detailed contents, methodology, demographics, and questionnaire for this report in Adobe Acrobat format.

To order this report, click here.